Latest filing published 12 Jan 2015 for Eiger BioPharmaceuticals, Inc., €9,495.
Insider track record
No signal scores available.
Jeffrey J. Rudy: trading record in brief
All filings by Jeffrey J. Rudy on record concern Eiger BioPharmaceuticals, Inc. The record holds 6 filings, for trades running from 14 November 2014 to 9 January 2015.
No open-market purchase appears, only 3 sales worth €447k. The rest of the record consists of 3 option exercises. Since January 2015: no purchases and 1 sale on the market.
The newest entry dates from 12 January 2015: an option exercise of €9,495, in Eiger BioPharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey J. Rudy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.12Common StockSEC:0001209191-15-003774:0
- 10,000 shares@ US$18.51Common StockSEC:0001209191-15-003774:1
- 10,000 shares@ US$1.12Common StockSEC:0001209191-14-074293:0
- 10,000 shares@ US$15.00Common StockSEC:0001209191-14-074293:1
- 18,000 shares@ US$1.12Common StockSEC:0001209191-14-069588:0
- 18,000 shares@ US$11.67Common StockSEC:0001209191-14-069588:1
6 of 6 declarations
